サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1750631

細胞・遺伝子治療バイオ分析検査サービスの世界市場規模、シェア、動向分析レポート：検査タイプ別、開発段階別、製品タイプ別、適応症別、地域別、セグメント別予測（2025年～2030年）

Cell And Gene Therapy Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Test Type, By Stage Of Development, By Product Type, By Indication, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 261 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
細胞・遺伝子治療バイオ分析検査サービスの世界市場規模、シェア、動向分析レポート：検査タイプ別、開発段階別、製品タイプ別、適応症別、地域別、セグメント別予測（2025年～2030年）
出版日: 2025年05月23日
発行: Grand View Research
ページ情報: 英文 261 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞・遺伝子治療バイオ分析検査サービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の細胞・遺伝子治療バイオ分析検査サービスの市場規模は、2025年～2030年にCAGR7.40%を記録し、2030年までに8億2,870万米ドルに達すると予測されています。

細胞・遺伝子治療に関連する研究開発活動の増加、細胞・遺伝子治療研究のための公的機関による投資の増加、希少疾患の治療における遺伝子・細胞治療の高い可能性が、市場の成長を促進する主な要因です。

細胞・遺伝子治療は、がん、自己免疫疾患、希少疾患の治療に広く採用されています。これらの治療法は患者の臨床状態を大幅に改善することが示されており、そのため多くの細胞・遺伝子治療薬候補がパイプラインに並んでいます。 例えば、米国細胞・遺伝子治療学会（American Society of Cell and Gene Therapy）によると、2023年1月現在、2,053以上の遺伝子治療薬と827の非遺伝子組換え細胞治療薬がパイプラインにあります。パイプラインにある細胞・遺伝子治療薬候補の数が多いことが、バイオ分析検査サービスの需要を促進しています。

公的機関や民間企業は、細胞治療や遺伝子治療に基づく研究に積極的に投資しています。例えば、2023年4月、カリフォルニア再生医療研究所は幹細胞・遺伝子治療研究に8,900万米ドルを投資しました。この資金は、持続性角膜上皮欠損の治療開発のために計画されました。今後、同様の資金調達が行われることで、予測期間中に生物分析検査サービスの需要が高まることが予想されます。

COVID-19パンデミックは、細胞・遺伝子治療バイオ分析検査サービス市場にマイナスの影響を与えました。このパンデミックでは、細胞治療や遺伝子治療に基づく臨床検査の大半が延期されました。しかし、COVID-19後の時代にはシナリオが変わりつつあり、多くの検査が再開されています。このことは、COVID-19後の期間における市場の成長を支えるものと予想されます。

細胞・遺伝子治療バイオ分析検査サービス市場レポートのハイライト

  • バイオアベイラビリティと生物学的同等性検査は、2024年の市場シェア35.44%で優位を占め、予測期間中も最速の成長が見込まれます。
  • 非臨床検査が2024年の市場を独占しました。開発段階セグメントは製品タイプに基づいてさらに分類され、遺伝子治療、遺伝子改変細胞治療、細胞治療が含まれます。
  • 2024年の製品別では、細胞治療が優位を占めています。細胞治療とは、損傷した組織や細胞を修復したり置き換えたりするためにヒト細胞を移植することです。遺伝子改変細胞治療セグメントは、予測期間中に最も速い成長を記録すると予想されています。
  • 腫瘍セグメントは市場を独占し、2024年に最大の収益シェアを占めました。希少疾患セグメントは予測期間中に最も速いCAGRを記録すると予測されています。
  • 北米が細胞・遺伝子治療バイオ分析検査サービス市場を独占し、2024年に41.57%の最大収益シェアを占めました。アジア太平洋の細胞・遺伝子治療バイオ分析検査サービスは、予測期間中に最も速いCAGRを記録すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 細胞・遺伝子治療バイオ分析検査サービス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 臨床検査件数分析（2024年）
    • 臨床検査総数：地域別
    • 臨床検査総数：フェーズ別
    • 臨床検査総数：研究デザイン別
    • 臨床検査総数：主要治療領域別
  • 価格モデル分析
  • テクノロジー情勢
  • 市場分析ツール
    • ポーターのファイブフォース分析
    • SWOT分析によるPESTEL
    • COVID-19の影響分析

第4章 細胞・遺伝子治療バイオ分析検査サービス市場：検査タイプの推定・動向分析

  • 細胞・遺伝子治療バイオ分析検査サービス市場（検査タイプ別：セグメントダッシュボード）
  • 細胞・遺伝子治療バイオ分析検査サービス市場（検査タイプ別：変動分析）
  • 検査タイプ別、2018年～2030年
  • バイオアベイラビリティと生物学的同等性検査
  • 薬物動態
  • 薬力学
  • その他

第5章 細胞・遺伝子治療バイオ分析検査サービス市場：製品タイプの推定・動向分析

  • 細胞・遺伝子治療バイオ分析検査サービス市場（製品タイプ別：セグメントダッシュボード）
  • 細胞・遺伝子治療バイオ分析検査サービス市場（製品タイプ別：変動分析）
  • 製品タイプ別、2018年～2030年
  • 遺伝子治療
    • 生体外
    • 生体内
  • 遺伝子改変細胞治療
    • CAR T細胞治療
    • CAR-NK細胞治療
    • TCR-T細胞治療
    • その他
  • 細胞治療

第6章 細胞・遺伝子治療バイオ分析検査サービス市場：開発段階の推定・動向分析

  • 細胞・遺伝子治療バイオ分析検査サービス市場（開発段階別：セグメントダッシュボード）
  • 細胞・遺伝子治療バイオ分析検査サービス市場（開発段階別：変動分析）
  • 開発段階別、2018年～2030年
  • 非臨床
    • 遺伝子治療
    • 遺伝子改変細胞治療
    • 細胞治療
  • 臨床
    • 遺伝子治療
    • 遺伝子改変細胞治療
    • 細胞治療

第7章 細胞・遺伝子治療バイオ分析検査サービス市場：適応症の推定・動向分析

  • 細胞・遺伝子治療バイオ分析検査サービス市場（適応症別：セグメントダッシュボード）
  • 細胞・遺伝子治療バイオ分析検査サービス市場（適応症別：変動分析）
  • 適応症別、2018年～2030年
  • 腫瘍
  • 感染症
  • 神経疾患
  • 希少疾患
  • その他

第8章 細胞・遺伝子治療バイオ分析検査サービス市場：地域の推定・動向分析

  • 地域市場ダッシュボード
  • 地域別市場シェア分析、2024年および2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 市場参入企業の分類
  • 企業市場シェア/評価分析、2024年
  • 企業プロファイル
    • BioAgilytix Labs
    • KCAS Bioanalytical Services
    • IQVIA, Inc.
    • Laboratory Corporation of America Holdings
    • Pharmaceutical Product Development, Inc.（Thermo Fisher Scientific Inc.）
    • Prolytix
    • Pharmaron
    • Charles River Laboratories
    • Syneos Health
    • SGS SA
    • Intertek Group Plc
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 4. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 5. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 6. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 7. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 8. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 10. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 11. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 12. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 13. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 14. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 15. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 16. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 17. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 18. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 19. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 20. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 21. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 22. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 23. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 24. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 25. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 27. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 28. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 29. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 30. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 31. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 32. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 33. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 34. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 35. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 36. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 37. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 38. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 39. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 40. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 41. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 42. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 43. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 44. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 45. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 46. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 47. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 48. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 49. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 50. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 51. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 52. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 53. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 54. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 55. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 56. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 57. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 58. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 59. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 60. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 61. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 67. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 68. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 69. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 70. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 71. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 72. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 73. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 74. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 75. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 76. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 77. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 78. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 79. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 80. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 81. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 82. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 83. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 84. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 85. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 86. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 87. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 88. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 89. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 90. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 91. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 93. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 94. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 95. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 96. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 97. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 98. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 99. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 100. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 101. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 102. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 103. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 109. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 110. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 111. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 112. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 117. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 118. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 119. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 120. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Cell & Gene Therapy Bioanalytical Testing Services Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type outlook and key takeaways
  • Fig. 20 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type movement analysis
  • Fig. 21 Bioavailability & Bioequivalence Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Pharmacokinetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Pharmacodynamics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Other Test Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type outlook and key takeaways
  • Fig. 26 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type movement analysis
  • Fig. 27 Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Ex-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 In-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 CAR T-cell therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 CAR-NK cell therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 TCR-T cell therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type outlook and key takeaways
  • Fig. 37 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type movement analysis
  • Fig. 38 Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication outlook and key takeaways
  • Fig. 47 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication movement analysis
  • Fig. 48 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Neurological disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Rare Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Regional Marketplace: Key Takeaways
  • Fig. 54 North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 MEA Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key company categorization
  • Fig. 106 Service heat map analysis
  • Fig. 107 Strategic framework
目次
Product Code: GVR-4-68040-078-3

Cell And Gene Therapy Bioanalytical Testing Services Market Growth & Trends:

The global cell and gene therapy bioanalytical testing services market size is expected to reach USD 828.7 million by 2030, registering a CAGR of 7.40% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing R&D activities related to cell and gene therapy, growth in investments by public organizations for cell and gene therapy research and high potential of gene and cell therapy in treating rare diseases are the key factors driving the growth of the market.

Cell and gene therapies have popularly been adopted in the treatment of cancer, autoimmune diseases, and rare diseases. These therapies have shown a significant improvement in patients' clinical conditions, owing to which a significant number of cell and gene therapy drug candidates are in the pipeline. For instance, according to the American Society of Cell and Gene Therapy, over 2,053 gene therapies and 827 non-genetically modified cell therapies were in the pipeline as of January 2023. High number of cell and gene therapy drug candidates in pipeline is promoting the demand for bioanalytical testing services.

Public and private organizations are actively investing in cell and gene therapy-based research. For instance, in April 2023, the California Institute for Regenerative Medicine invested USD 89.0 million in stem cell and gene therapy research. This funding was planned for the development of therapy in the treatment of persistent corneal epithelial defects. Similar fundings in the future is expected to boost the demand for bioanalytical testing services in the forecasted period.

The COVID-19 pandemic had a negative impact on the market for cell & gene therapy bioanalytical testing services. The majority of the cell and gene therapy-based trials were postponed in the pandemic. However, in the post COVID-19 era, the scenario is changing, and many trials are resumed. This is expected to support market growth in the post-COVID-19 period.

Cell And Gene Therapy Bioanalytical Testing Services Market Report Highlights:

  • The bioavailability & bioequivalence studies dominated with a market share of 35.44% in 2024 and are also expected to witness the fastest growth over the forecast period.
  • The non-clinical segment dominated the market in 2024. The stage of development segment has been further classified based on the product type, which includes gene therapy, gene-modified cell therapy, and cell therapy.
  • The cell therapy segment dominated the product segment in 2024. Cell therapy is the transplantation of human cells to repair or replace damaged tissue or cells. The gene-modified cell therapy segment is expected to register the fastest growth during the forecast period.
  • The oncology segment dominated the market and accounted for the largest revenue share in 2024. The rare diseases segment is expected to register the fastest CAGR during the forecast period.
  • North America dominated the cell and gene therapy bioanalytical testing services market and accounted for the largest revenue share of 41.57% in 2024. Asia Pacific cell and gene therapy bioanalytical testing services are anticipated to witness the fastest CAGR over the forecast period.

Table of Content

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cell & Gene Therapy Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Significant Number of Cell & Gene Therapy Drug Candidates Under Clinical Trials
      • 3.2.1.2. High Public and Private Investments Across Research and Development for Novel Cell & Gene Products
      • 3.2.1.3. High Focus of Biopharmaceutical Companies to Reduce Operational Costs Promoting the Demand for Outsourcing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Availability of Alternative Treatment Options at Lower Cost
      • 3.2.2.2. Quality Issues Associated With Outsourcing
  • 3.3. Clinical Trials Volume Analysis (2024)
    • 3.3.1. Total Number Of Clinical Trials By Region
    • 3.3.2. Total Number Of Clinical Trials, By Phase
    • 3.3.3. Total Number Of Clinical Trials, By Study Design
    • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis

  • 4.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type: Segment Dashboard
  • 4.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type: Movement Analysis
  • 4.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Test Type, 2018 - 2030 (USD Million)
  • 4.4. Bioavailability & Bioequivalence Studies
    • 4.4.1. Bioavailability & Bioequivalence Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pharmacokinetics
    • 4.5.1. Pharmacokinetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Pharmacodynamics
    • 4.6.1. Pharmacodynamics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type Estimates & Trend Analysis

  • 5.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type: Segment Dashboard
  • 5.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type: Movement Analysis
  • 5.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Product Type, 2018 - 2030 (USD Million)
  • 5.4. Gene Therapy
    • 5.4.1. Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Ex-vivo
      • 5.4.2.1. Ex-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. In-vivo
      • 5.4.3.1. In-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Gene-Modified Cell Therapy
    • 5.5.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. CAR T-cell therapies
      • 5.5.2.1. CAR T-cell therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. CAR-NK cell therapy
      • 5.5.3.1. CAR-NK cell therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. TCR-T cell therapy
      • 5.5.4.1. TCR-T cell therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Other
      • 5.5.5.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cell Therapy
    • 5.6.1. Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type, Estimates & Trend Analysis

  • 6.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Stage of Development by Product Type: Segment Dashboard
  • 6.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Stage of Development by Product Type: Movement Analysis
  • 6.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Stage of Development by Product Type, 2018 - 2030 (USD Million)
  • 6.4. Non-Clinical
    • 6.4.1. Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Gene Therapy
      • 6.4.2.1. Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Gene-Modified Cell Therapy
      • 6.4.3.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Cell Therapy
      • 6.4.4.1. Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Clinical
    • 6.5.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Gene Therapy
      • 6.5.2.1. Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Gene-Modified Cell Therapy
      • 6.5.3.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Cell Therapy
      • 6.5.4.1. Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cell & Gene Therapy Bioanalytical Testing Services Market: Indication Estimates & Trend Analysis

  • 7.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication: Segment Dashboard
  • 7.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication: Movement Analysis
  • 7.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Indication, 2018 - 2030 (USD Million)
  • 7.4. Oncology
    • 7.4.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Neurological disorders
    • 7.6.1. Neurological disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Rare Diseases
    • 7.7.1. Rare Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Cell & Gene Therapy Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Share/Assessment Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. BioAgilytix Labs
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. KCAS Bioanalytical Services
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. IQVIA, Inc.
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Laboratory Corporation of America Holdings
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Prolytix
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Pharmaron
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Charles River Laboratories
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Syneos Health
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. SGS SA
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Intertek Group Plc
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives